Ebos Group Ltd EBOSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $28.00
- Day Range
- $22.44–22.44
- 52-Week Range
- $22.44–28.25
- Bid/Ask
- $0.00 / $12,521.02
- Market Cap
- $4.30 Bil
- Volume/Avg
- 24,061 / 20,214
Key Statistics
- Price/Earnings (Normalized)
- 31.41
- Price/Sales
- 0.66
- Dividend Yield (Trailing)
- 2.16%
- Dividend Yield (Forward)
- 1.47%
- Total Yield
- 2.16%
Company Profile
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Core
- Total Number of Employees
- 5,000
- Website
- https://www.ebosgroup.com
Competitors
Valuation
|
Metric
|
EBOSF
|
CAH
|
COR
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.41 | 13.78 | 17.41 |
Price/Book Value | 3.37 | — | 41.23 |
Price/Sales | 0.66 | 0.11 | 0.16 |
Price/Cash Flow | 20.57 | 10.22 | 13.91 |
Price/Earnings
EBOSF
CAH
COR
Financial Strength
|
Metric
|
EBOSF
|
CAH
|
COR
|
|---|---|---|---|
Quick Ratio | 0.71 | 0.43 | 0.50 |
Current Ratio | 1.24 | 0.98 | 0.89 |
Interest Coverage | 5.05 | 18.37 | 9.10 |
Quick Ratio
EBOSF
CAH
COR
Profitability
|
Metric
|
EBOSF
|
CAH
|
COR
|
|---|---|---|---|
Return on Assets (Normalized) | 4.19% | 4.01% | 4.19% |
Return on Equity (Normalized) | 11.55% | — | 373.63% |
Return on Invested Capital (Normalized) | 8.77% | 97.71% | 47.73% |
Return on Assets
EBOSF
CAH
COR
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Sgshgmdw | Gbkvbnb | $69.5 Bil | |
COR
| Cencora Inc | Kmtsqbwp | Byjck | $44.7 Bil | |
CAH
| Cardinal Health Inc | Hktnskbrw | Mtzxw | $24.1 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Lmnjyk | $8.2 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Dgtjzvt | $8.2 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Hydhwb | $7.8 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Mlttt | $7.8 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Fgvxhz | $7.6 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Qgzy | $3.4 Bil | |
MEPDF
| Medipal Holdings Corp | — | Xllb | $3.4 Bil |